Gilliland Jeter Wealth Management LLC Sells 19 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Gilliland Jeter Wealth Management LLC trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,020 shares of the medical equipment provider’s stock after selling 19 shares during the quarter. Gilliland Jeter Wealth Management LLC’s holdings in Intuitive Surgical were worth $2,620,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. M.E. Allison & CO. Inc. purchased a new position in Intuitive Surgical during the fourth quarter worth about $449,000. Seilern Investment Management Ltd purchased a new position in Intuitive Surgical during the fourth quarter worth about $82,517,000. Exome Asset Management LLC grew its position in Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares in the last quarter. China Universal Asset Management Co. Ltd. grew its position in Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after buying an additional 525 shares in the last quarter. Finally, Consolidated Planning Corp grew its position in Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after buying an additional 1,198 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 5,940 shares of company stock valued at $3,333,485. 0.80% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. BTIG Research boosted their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Citigroup boosted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Robert W. Baird upped their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. Finally, Jefferies Financial Group upped their price objective on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Trading Down 0.4 %

Shares of ISRG opened at $588.50 on Friday. The company has a market cap of $209.61 billion, a price-to-earnings ratio of 91.81, a P/E/G ratio of 5.51 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The business’s fifty day simple moving average is $553.03 and its two-hundred day simple moving average is $512.59.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.